Aurinia Pharmaceuticals Inc. AUPH
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2001-07-16
Aurinia Pharmaceuticals Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 9,272,162 | $52.9M |
| TWO SIGMA INVESTMENTS, LP | 3,428,705 | $50.8M |
| RENAISSANCE TECHNOLOGIES LLC | 1,663,835 | $24.7M |
| D. E. Shaw & Co., Inc. | 1,572,983 | $23.3M |
| AQR CAPITAL MANAGEMENT LLC | 948,810 | $14.1M |
| CITADEL ADVISORS LLC | 406,674 | $6.0M |
| MILLENNIUM MANAGEMENT LLC | 117,169 | $1.7M |
Source: SEC EDGAR filings · CIK 0001600620 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.